Live Breaking News & Updates on Corbus pharmaceuticals holdings

Stay updated with breaking news from Corbus pharmaceuticals holdings. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Corbus Pharmaceuticals (NASDAQ:CRBP) Sets New 52-Week High at $50.30

Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP – Get Free Report)’s share price hit a new 52-week high on Tuesday . The stock traded as high as $50.30 and last traded at $50.00, with a volume of 58166 shares trading hands. The stock had previously closed at $48.55. Analyst Upgrades and Downgrades Several equities analysts recently weighed […]

Canada , Altitude-crest-partners-inc , Janus-henderson-group , Nasdaq , Royal-bank , Corbus-pharmaceuticals-holdings-inc , Corbus-pharmaceuticals , Ikarian-capital , Corbus-pharmaceuticals-trading-down , Pricet-rowe-associates-inc , Vanguard-group-inc

Corbus Pharmaceuticals (NASDAQ:CRBP) Downgraded to Sell at StockNews.com

Corbus Pharmaceuticals (NASDAQ:CRBP) Downgraded to Sell at StockNews.com
kopsource.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from kopsource.com Daily Mail and Mail on Sunday newspapers.

Mirae-asset-global-investments-co , Securities-exchange-commission , Corbus-pharmaceuticals-holdings-inc , Corbus-pharmaceuticals , Jefferies-financial-group , Corbus-pharmaceuticals-price-performance , Nasdaq , News-ratings-for-corbus-pharmaceuticals-daily , Corbus-pharmaceuticals-company-profile , Exchange-commission , Get-free-report

Corbus Pharmaceuticals (NASDAQ:CRBP) Given New $60.00 Price Target at Oppenheimer

Corbus Pharmaceuticals (NASDAQ:CRBP) Given New $60.00 Price Target at Oppenheimer
dailypolitical.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dailypolitical.com Daily Mail and Mail on Sunday newspapers.

Corbus-pharmaceuticals , Mirae-asset-global-investments-co , Jefferies-financial-group , News-ratings-for-corbus-pharmaceuticals-daily , Corbus-pharmaceuticals-holdings-inc , Institutional-trading-of-corbus-pharmaceuticals , Nasdaq , Corbus-pharmaceuticals-stock , Securities-exchange-commission , Free-report , Financial-group

Corbus Pharmaceuticals (NASDAQ:CRBP) Price Target Raised to $60.00 at Oppenheimer

Corbus Pharmaceuticals (NASDAQ:CRBP) Price Target Raised to $60.00 at Oppenheimer
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Jefferies-financial-group , Corbus-pharmaceuticals-holdings-inc , Hedge-funds-weigh-in-on-corbus-pharmaceuticals , News-ratings-for-corbus-pharmaceuticals-daily , Corbus-pharmaceuticals-stock , Exchange-commission , Nasdaq , Corbus-pharmaceuticals , Get-free-report , Financial-group , Cormorant-asset-management

Real Estate Agent in Raleigh, NC, Guides Homeowners to Success

Real Estate Agent in Raleigh, NC, Guides Homeowners to Success
openpr.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from openpr.com Daily Mail and Mail on Sunday newspapers.

United-states , American , Eli-lilly , Vincerx-pharma-inc , Rhythm-pharmaceuticals , Corbus-pharmaceuticals-holdings-inc , Therapeutics-inc , Actinium-pharmaceuticals , Federal-reserve , Nasdaq , Phathom-pharmaceuticals , Bristol-meyers

Short Interest in Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP) Expands By 560.9%

Short Interest in Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP) Expands By 560.9%
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

News-ratings-for-corbus-pharmaceuticals-daily , Hedge-funds-weigh-in-on-corbus-pharmaceuticals , Insider-activity-at-corbus-pharmaceuticals , Corbus-pharmaceuticals-holdings-inc , Corbus-pharmaceuticals , Corbus-pharmaceuticals-price-performance , Vident-investment-advisory , Jefferies-financial-group , Blackrock-inc , Nasdaq , Renaissance-technologies

Short Interest in Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP) Expands By 560.9%

Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP – Get Free Report) was the recipient of a large growth in short interest during the month of March. As of March 15th, there was short interest totalling 403,800 shares, a growth of 560.9% from the February 29th total of 61,100 shares. Based on an average daily volume of 886,400 […]

Corbus-pharmaceuticals , Insider-activity-at-corbus-pharmaceuticals , Hedge-funds-weigh-in-on-corbus-pharmaceuticals , Blackrock-inc , Corbus-pharmaceuticals-price-performance , Corbus-pharmaceuticals-holdings-inc , News-ratings-for-corbus-pharmaceuticals-daily , Renaissance-technologies , Nasdaq , Jefferies-financial-group , Vident-investment-advisory

Corbus Pharmaceuticals to Present at the Oppenheimer 34th Annual Healthcare Life Sciences Conference

Corbus Pharmaceuticals to Present at the Oppenheimer 34th Annual Healthcare Life Sciences Conference
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Massachusetts , United-states , Yuval-cohen , Linkedin , Bruce-macklemanaging-directorlifesci-advisors , Securities-exchange , Nasdaq , Twitter , Corbus-pharmaceuticals-holdings-inc , Facebook , Healthcare-life-sciences-conference , Sean-moranchief-financial-officercorbus-pharmaceuticals